High-grade Endometrial Carcinoma With a Hepatoid Carcinoma-like Component

Int J Gynecol Pathol. 2023 Jan 1;42(1):63-67. doi: 10.1097/PGP.0000000000000852. Epub 2022 Jan 25.

Abstract

Endometrial carcinoma with hepatoid differentiation is rare and <20 reported cases have been reported as endometrial hepatoid carcinoma (EHC). We present a case of EHC associated with serous carcinoma in a 76-yr-old Japanese woman. The hepatoid component showed trabecular, pseudoglandular, and diffuse proliferation of hepatoid cells. The hepatoid cells were positive for α-fetoprotein, Hep-Per-1, glypican 3, and HNF-1β, weakly and focally positive for SALL4, and negative for PAX8. Both of the serous and hepatoid components showed overexpression of p53. The serum α-fetoprotein on postoperative day 5 was 3691 ng/mL. The postoperative course has remained uneventful for 4 yr. These findings suggested that EHC developed from serous carcinoma by acquiring hepatocytic features and losing Müllerian features. Both serous and hepatoid components showed p53 overexpression, suggesting they share a TP53 mutation as a common primary driver.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma* / pathology
  • Endometrial Neoplasms* / genetics
  • Female
  • Hepatocytes / pathology
  • Humans
  • Tumor Suppressor Protein p53 / genetics
  • alpha-Fetoproteins

Substances

  • alpha-Fetoproteins
  • Tumor Suppressor Protein p53